BOS
TDOC icon

Bingham Osborn & Scarborough’s Teladoc Health TDOC Stock Holding History

Bingham Osborn & Scarborough’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,689
Closed -$338K – 144
2020
Q4 		$338K Buy
+1,689
New +$343K 0.03% 102

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DVF
Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Bingham Osborn & Scarborough's TDOC Position: Q1 2021 in Review

Bingham Osborn & Scarborough sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,689 shares — an estimated $338K sold.

Bingham Osborn & Scarborough first reported a position in TDOC in Q4 2020 and held it in 1 quarter. The position peaked at $338K in Q4 2020. 889 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

  • Bingham Osborn & Scarborough reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 1,689 Teladoc Health shares in Q1 2021, an estimated $338K.
  • Bingham Osborn & Scarborough first reported a position in Teladoc Health in Q4 2020 and held it in 1 quarter.
  • Bingham Osborn & Scarborough's Teladoc Health position peaked at $338K in Q4 2020.
  • 889 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Bingham Osborn & Scarborough's 13F filing for Q1 2021, filed 4 May 2021.